Search results
Earnings call: Lucid Diagnostics Q1 2024 revenue climbs 124%
Investing.com· 3 hours agoLucid (NASDAQ: LCID ) Diagnostics Inc. (LUCD) reported a significant increase in its first-quarter...
Accelerate Diagnostics Reports Q1 Loss, Misses Revenue Estimates - Accelerate Diagnostics...
Benzinga· 4 days agoAccelerate Diagnostics AXDX came out with a quarterly loss of $0.88 per share versus the Zacks...
Co-Diagnostics First Quarter 2024 Earnings: Misses Expectations
Simply Wall St. via Yahoo Finance· 19 hours agoCo-Diagnostics (NASDAQ:CODX) First Quarter 2024 Results Key Financial Results Net loss: US$9.31m...
Earnings call: Co-Diagnostics Q1 2024 financial results and updates By Investing.com
Investing.com· 4 days agoCo-Diagnostics , Inc. (NASDAQ:CODX) reported its financial results for the first quarter ended March...
Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results
WPRI Providence· 18 hours agoLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary ...
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoAccelerate Diagnostics, Inc. (NASDAQ:AXDX) Q1 2024 Earnings Call Transcript May 8, 2024 Accelerate ...
Dementia Action Week 2024: the future of Alzheimer’s diagnostics
Medical Device Network via Yahoo Finance· 21 hours agoNow, all eyes are on Eli Lily’s donanemab, which had positive data released from a Phase III study...
Quest Diagnostics (DGX) Grows in Digital Pathology With New Deal
Zacks via Yahoo Finance· 7 days agoQuest Diagnostics DGX recently announced a strategic collaboration with PathAI, a global leader in...
Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results
The Record Gazette· 5 days agoAccelerate Diagnostics, Inc. (PRNewsfoto/Accelerate Diagnostics)
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results
Colorado Springs Gazette· 4 days agoCo-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Dx," or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of ...